Subscribe
istock-839222794-nicoelnino-1
NicoElnino / iStockphoto.com
27 July 2018Americas

GSK unites with 23andMe amid R&D revamp

GSK revealed its new approach to research and development (R&D) earlier this week, including a partnership with DNA testing company 23andMe.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
GSK unites with CRISPR pioneer Doudna
14 June 2019   British-based pharmaceutical company GSK has entered into a five-year collaboration with the University of California to explore how gene mutations cause disease and accelerate drug discovery.
Americas
FDA orders 23andMe to cease PGS sales
26 November 2013   The US Food and Drug Administration has told genetics company 23andMe to stop selling its Personal Genome Service product immediately.
Americas
23andMe’s ‘designer baby’ patent sparks controversy
8 October 2013   Personal genomics company 23andMe has received a patent covering its Family Traits Inheritance Calculator tool that lets prospective parents see what traits their children may inherit.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
GSK unites with CRISPR pioneer Doudna
14 June 2019   British-based pharmaceutical company GSK has entered into a five-year collaboration with the University of California to explore how gene mutations cause disease and accelerate drug discovery.
Americas
FDA orders 23andMe to cease PGS sales
26 November 2013   The US Food and Drug Administration has told genetics company 23andMe to stop selling its Personal Genome Service product immediately.
Americas
23andMe’s ‘designer baby’ patent sparks controversy
8 October 2013   Personal genomics company 23andMe has received a patent covering its Family Traits Inheritance Calculator tool that lets prospective parents see what traits their children may inherit.

More on this story

Americas
GSK unites with CRISPR pioneer Doudna
14 June 2019   British-based pharmaceutical company GSK has entered into a five-year collaboration with the University of California to explore how gene mutations cause disease and accelerate drug discovery.
Americas
FDA orders 23andMe to cease PGS sales
26 November 2013   The US Food and Drug Administration has told genetics company 23andMe to stop selling its Personal Genome Service product immediately.
Americas
23andMe’s ‘designer baby’ patent sparks controversy
8 October 2013   Personal genomics company 23andMe has received a patent covering its Family Traits Inheritance Calculator tool that lets prospective parents see what traits their children may inherit.

More features

WATCH: The transparency tightrope—balancing innovation, regulation, and IP protection in a new era
Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC